Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Allarity Therapeutics, Inc. (ALLR) is now available.
Allarity Therapeutics, Inc. has announced they’ve received additional time until May 14, 2024, to meet Nasdaq’s compliance requirements. This development offers the company a vital opportunity to address and rectify the issues concerning their listing status, providing shareholders and potential investors a renewed sense of confidence in the company’s ability to uphold financial market standards.
See more data about ALLR stock on TipRanks’ Stock Analysis page.